Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers-Reference-Cited by-同舟云学术

Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers

Published:2024-05 Issue: Volume:118 Page:52-68
ISSN:0889-1591
Container-title:Brain, Behavior, and Immunity
language:en
Short-container-title:Brain, Behavior, and Immunity

Author:

Poletti Sara^ORCID,Zanardi Raffaella,Mandelli Alessandra,Aggio Veronica,Finardi Annamaria,Lorenzi Cristina,Borsellino Giovanna,Carminati Matteo,Manfredi Elena,Tomasi Enrico,Spadini Sara,Colombo Cristina,Drexhage Hemmo A.,Furlan Roberto,Benedetti Francesco

Funder

H2020

Publisher

Elsevier BV

Reference105 articles.

1. An Introduction to Categorical Data Analysis;Agresti,1996

2. Cutoff threshold of variable importance in projection for variable selection;Akarachantachote;Int J Pure Appl Math,2014

3. Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice;Alves;Brain,2016

4. Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium;Arteaga-Henriquez;Front. Psych.,2019

5. Neuroendocrine and viral correlates of premature immunosenescence;Bauer;Ann. N. Y. Acad. Sci.,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring sedentary behavior, neutrophil-to-lymphocyte ratio, and depression: Mediation analysis in NHANES;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-09

2. Low-dose interleukin-2 in patients with bipolar depression: A phase 2 randomised double-blind placebo-controlled trial;Brain, Behavior, and Immunity;2024-09

3. Causal role of immune cells in bipolar disorder: a Mendelian randomization study;Frontiers in Psychiatry;2024-08-16

4. Pharmacotherapeutic value of inflammatory and neurotrophic biomarkers in bipolar disorder: A systematic review;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-08

5. Low-dose interleukin-2 in patients with bipolar depression: a phase 2 randomised double-blind placebo-controlled trial;2024-07-19